Lexis Nexis’s The Drugs and Cosmetics Act, 1940 (Bare Act) – 2021 Edition
Original price was: ₹695.00.₹530.00Current price is: ₹530.00.
Lexis Nexis’s The Drugs and Cosmetics Act, 1940 along with Rules, 1945 as amended by (Ninth Amendment) Rules, 2017 along with allied Act and Rules (Bare Act) – 2021 Edition. The Drugs and Cosmetics Act, 1940 (23 of 1940) with • The Drugs and Cosmetics Rules, 1945 as amended by (Twelfth Amendment) Rules, 2019 • The Drugs (Control) Act, 1950 Repealed by the Repealing and Amending Act, 2016 (23 of 2016).
Details
- Binding : Softcover
- Publisher : Lexis Nexis
- Author : Universal
- Edition : 2021
- Language : English
- ISBN-10 : D8
- ISBN-13 : D8
Related products
-
Add to cart
This book aims to explain the readers how to read, understand, analyse and interlink the voluminous information available in the financial statement with the help of charts, case analysis, etc. In other words, this book provides in-depth analysis, stepwise approach with the use of case analysis, to understand & decode the financial statements.
-
Add to cart
GST Practice Manual is a comprehensive guide in understanding the ‘background’, ‘concepts’, ‘execution’, ‘challenges’, and ‘solution(s)’ involved in your ‘day-to-day’ compliance of GST. It explains the provisions of the GST law in a lucid manner.
-
Read more
FEMA & FDI Ready Reckoner provides complete and accurate information about all provisions of the Foreign Exchange Management Act, 1999 (FEMA). It also includes guidance on all practical issues faced by companies and FEMA professionals. Key features of this book are as follows: Topic-wise commentary on FEMA Analysis of all provisions of FEMA with relevant …
-
Read more
Taxmann’s Company Law Manual is a compendium of Companies Act, 2013 along with Relevant Rules framed thereunder. In other words, it contains Compilation of Amended, Updated & Annotated text of the Companies Act, 2013 [as amended by the Companies (Amendment) Act, 2020] along with Amended Schedules (III & V), Circulars, Notifications, SS-1 to SS-4, and ICSI Guidance Note on CSR.
Reviews
There are no reviews yet.